[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100555009":3},{"organization":4,"armGroups":7,"interventions":24,"overallOfficials":35,"centralContacts":39,"locations":48,"responsibleParty":83,"collaborators":85,"id":91,"slug":92,"hasResults":93,"nctId":94,"briefTitle":95,"officialTitle":96,"acronym":97,"eligibilityCriteria":98,"healthyVolunteers":99,"sex":100,"minAge":101,"maxAge":102,"enrollmentInfo":103,"targetDuration":28,"studyType":106,"phases":107,"briefSummary":109,"conditions":110,"keywords":112,"overallStatus":51,"whyStopped":28,"lastUpdateSubmitDate":120,"lastUpdatePostDateStruct":121,"startDateStruct":124,"completionDateStruct":126,"leadSponsor":128,"locationsCount":129},{"fullName":5,"class":6},"Cliniques universitaires Saint-Luc- Université Catholique de Louvain","OTHER",[8,14,19],{"label":9,"type":10,"description":11,"interventionNames":12},"control group","ACTIVE_COMPARATOR","in this control group, patients will perform non-cardiovascular non-intensity training (stretching, meditation).",[13],"Other: Low intensity exercise training",{"label":15,"type":10,"description":16,"interventionNames":17},"moderate-intensity low interval training group","In this group, patients will perform moderate-intensity low interval training.",[18],"Other: Moderate intensity exercise training",{"label":20,"type":10,"description":21,"interventionNames":22},"high-intensity interval training","In this group, patients willp erform high-intensity interval training.",[23],"Other: High-intensity interval training",[25,29,32],{"type":6,"name":26,"description":26,"armGroupLabels":27,"otherNames":28},"High-intensity interval training",[20],null,{"type":6,"name":30,"description":30,"armGroupLabels":31,"otherNames":28},"Moderate intensity exercise training",[15],{"type":6,"name":33,"description":33,"armGroupLabels":34,"otherNames":28},"Low intensity exercise training",[9],[36],{"name":37,"affiliation":5,"role":38},"Nicolas Lanthier, MD, PhD","PRINCIPAL_INVESTIGATOR",[40,45],{"name":41,"role":42,"phone":43,"phoneExt":28,"email":44},"Guillaume Henin, MD, PhD student","CONTACT","0032494312548","guillaume.henin@uclouvain.be",{"name":37,"role":42,"phone":46,"phoneExt":28,"email":47},"003227647089","nicolas.lanthier@saintluc.uclouvain.be",[49,69],{"facility":50,"status":51,"city":52,"state":28,"zip":53,"country":54,"countryCode":55,"cosmosGeoPoint":56,"geoPoint":61,"contacts":62},"Cliniques universitaires Saint-Luc","RECRUITING","Brussels","1200","Belgium","BE",{"type":57,"coordinates":58},"Point",[59,60],4.34878,50.85045,{"lat":60,"lon":59},[63,64,65,66],{"name":41,"role":42,"phone":43,"phoneExt":28,"email":44},{"name":37,"role":42,"phone":46,"phoneExt":28,"email":47},{"name":37,"role":38,"phone":28,"phoneExt":28,"email":28},{"name":67,"role":68,"phone":28,"phoneExt":28,"email":28},"Audrey Loumaye, MD, PhD","SUB_INVESTIGATOR",{"facility":70,"status":51,"city":71,"state":28,"zip":72,"country":54,"countryCode":55,"cosmosGeoPoint":73,"geoPoint":77,"contacts":78},"Centre d'investigation clinique en nutrition","Louvain-la-Neuve","1348",{"type":57,"coordinates":74},[75,76],4.61443,50.66829,{"lat":76,"lon":75},[79,80],{"name":41,"role":42,"phone":28,"phoneExt":28,"email":28},{"name":81,"role":42,"phone":28,"phoneExt":28,"email":82},"louise Deldicque, PhD","louise.deldicque@uclouvain.be",{"type":84,"investigatorFullName":28,"investigatorTitle":28,"investigatorAffiliation":28,"oldNameTitle":28,"oldOrganization":28},"SPONSOR",[86,89],{"name":87,"class":88},"Concerted Research Action","UNKNOWN",{"name":90,"class":6},"Fonds National de la Recherche Scientifique","100555009","targeting-the-skeletal-muscle-to-treat-metabolic-dysfunction-associated-steatotic-liver-disease-100555009",false,"NCT06506513","Targeting the Skeletal Muscle to Treat Metabolic Dysfunction-associated Steatotic Liver Disease","Targeting Myosteatosis Though Physical Exercise to Treat Metabolic Dysfunction-associated Steatotic Liver Disease","MYO-MASLD","Inclusion Criteria:\n\n* confirmed MASLD at abdominal imaging\n* confirmed excessive muscle lipid content at imaging\n* stable weight\n\nExclusion Criteria:\n\n* severe comorbidities including active malignancies, neuromuscular degenerative diseases\n* contraindications to physical activity\n* excessive alcohol consumption",true,"ALL","18 Years","70 Years",{"count":104,"type":105},60,"ESTIMATED","INTERVENTIONAL",[108],"NA","Muscle changes including myosteatosis are reported as highly prevalent in metabolic dysfunction-associated steatotic liver disease (MASLD). Recent studies highlighted a link between muscle fat content and liver disease severity. Conversely, MASLD histological remission though diet or metabolic surgeries is also linked to a decrease in muscle fat content. Therefore, skeletal muscle appears as a potential target to treat MASLD.",[111],"Metabolic Dysfunction-associated Steatotic Liver Disease",[113,114,115,116,117,118,119],"metabolic dysfunction-associated steatotic liver disease","MASLD","physical activity","myosteatosis","magnetic resonance imaging","magnetic resonance specroscopy","muscle biopsy","2026-07-10",{"date":122,"type":123},"2026-07-14","ACTUAL",{"date":125,"type":123},"2025-09-01",{"date":127,"type":105},"2027-09",{"name":5,"class":6},2]